US earnings crumble

US stocks have hit new record highs despite the deteriorating earnings outlook for American companies.

After a shaky start to the year, stockmarkets have hit new highs. America's S&P 500 index, which usually sets the global tone, has hit a new record around 2,100. Positive data in Europe and optimism over potential deals in Ukraine and Greece have bolstered stocks. Liquidity continues to provide a lift too, of course. According to Evercore ISI, an investment bank, central banks across the world have loosened monetary policy 514 times in the past three years.

All this is just as well as far as the S&P is concerned, because the outlook for US earnings has deteriorated. Around four-fifths of the S&P's 500 firms have now reported their profits for the final quarter of 2014. So far, profits have grown by around 4.1% year-on-year, while sales have expanded by 1.6%. Strip out Apple, and earnings are growing at less than 2%.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.